REVBW
Revelation Biosciences IncKey Statistics
About Revelation Biosciences Inc
Revelation Biosciences Inc is an innovative biotechnology company specializing in the development of advanced therapeutic solutions for respiratory diseases, notably allergies and asthma. Leveraging its proprietary platform, Revelation addresses significant unmet medical needs through cutting-edge research and development initiatives. The company is committed to enhancing patient outcomes and actively collaborates with industry stakeholders, ensuring compliance with the intricate regulatory landscape of the biopharmaceutical sector. With a strong pipeline and an emphasis on scientific rigor, Revelation is strategically positioned to deliver impactful therapies that could transform the lives of patients suffering from respiratory conditions.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-9.04M |
| Operating Margin | 0.00% |
| Return on Equity | -131.40% |
| Return on Assets | -62.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $5.59 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $3.27M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |